AlphaYouJP
Insider selling
Jason Paul Steik sold $54K of Pennant Group, Inc. (PNTG) stock
Jason Paul Steik, Chief Clinical Officer of Pennant Group, Inc. (PNTG), sold 1,394 shares of PNTG stock worth $54K, per an SEC Form 4 filed Aug 10, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 6, 2026, 4 days before it was made public.
PNTG has moved -0.3% since the trade date, from $39.06 to $38.96 (Sep 21, 2026 close).
- Traded
- Aug 6, 2026
- Disclosed
- Aug 10, 2026
- Filing delay
- 4 days
- Price since
- -0.3%
- Role
- Chief Clinical Officer
- Source
- SEC Form 4
More PNTG insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.